An Elevated High-Sensitivity C-Reactive Protein Level Is Associated with Unfavorable Functional Outcomes of Small-Artery Occlusion in Patients without Diabetes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Neurology

• Publication date

  2017-06-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000477929PMID 28624820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between hs-CRP Levels and the Outcomes of Patients with Small-Artery Occlusion

  2016cited by this paper
• Association between Elevated Hemoglobin A1c Levels and the Outcomes of Patients with Small-Artery Occlusion: A Hospital-Based Study

  2016cited by this paper
• Comparison of Risk Factor between Lacunar Stroke and Large Artery Atherosclerosis Stroke: A Cross-Sectional Study in China

  2016cited by this paper
• Sex Differences in Stroke Subtypes, Severity, Risk Factors, and Outcomes among Elderly Patients with Acute Ischemic Stroke

  2015cited by this paper
• C-reactive protein and long-term ischemic stroke prognosis.

  2014cited by this paper
• Differences of Circulating Inflammatory Markers between Large- and Small Vessel Disease in Patients with Acute Ischemic Stroke

  2013cited by this paper
• Homocysteine and C-Reactive Protein Associated with Progression and Prognosis of Intracranial Branch Atheromatous Disease

  2013cited by this paper
• Differential Risk Factors for Lacunar Stroke Depending on the MRI (White and Red) Subtypes of Microangiopathy

  2012cited by this paper
• Risk factors for lacune subtypes in the Atherosclerosis Risk in Communities (ARIC) Study

  2012cited by this paper
• A Thermophilic Ionic Liquid-Tolerant Cellulase Cocktail for the Production of Cellulosic Biofuels

  2012cited by this paper
• Inflammation in ischemic stroke subtypes.

  2012cited by this paper
• [Changes in serum high mobility group box-1 protein and high-sensitivity C-reactive protein in patients with acute cerebral infarction and their clinical significance].

  2012cited by this paper
• C-Reactive Protein and Nitric Oxide Levels in Ischemic Stroke and Its Subtypes: Correlation with Clinical Outcome

  2011cited by this paper
• Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume

  2011cited by this paper
• C-reactive protein levels and risk of stroke and its subtype in Japanese: The Circulatory Risk in Communities Study (CIRCS).

  2011cited by this paper
• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

  2010cited by this paper
• Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.

  2010cited by this paper
• C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death

  2009cited by this paper
• Interrelationships between inflammation, C-reactive protein, and insulin resistance.

  2006cited by this paper
• Serum C-Reactive Protein Concentration and Genotype in Relation to Ischemic Stroke Subtype

  2006cited by this paper
• Optimizing Cutoff Scores for the Barthel Index and the Modified Rankin Scale for Defining Outcome in Acute Stroke Trials

  2005cited by this paper
• C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study

  2005cited by this paper
• Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors.

  2003cited by this paper
• Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke

  2001cited by this paper
• Effect of Prior Aspirin Use on Stroke Severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST)

  2001cited by this paper
• C-reactive protein and outcome after first-ever ischemic stroke.

  2000cited by this paper
• Essential hypertension. Part I: definition and etiology.

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Inflammation in cardiovascular disease: cart, horse, or both?

  1998cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Lacunar strokes and infarcts

  1982cited by this paper
• COMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES *

  1982cited by this paper

• Herbal Insights: Exploring the Therapeutic Potential of Indian Dietary Herbs in Diabetic Cardiomyopathy Management

  2024cites this paper
• The role of high-sensitivity C-reactive protein serum levels in the prognosis for patients with stroke: a meta-analysis

  2023cites this paper
• Related factors based on non-targeted metabolomics methods in minor ischaemic stroke

  2022cites this paper
• Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication

  2021cites this paper
• Association Between Long-term Functional Outcome and Change in hs-CRP Level in Patients With Acute Ischemic Stroke

  2020cites this paper
• C-reactive Protein, Infection, and Outcome After Acute Ischemic Stroke: A Registry and Systematic Review.

  2019cites this paper
• The association between high-sensitivity C-reactive protein at admission and progressive motor deficits in patients with penetrating artery infarctions

  2019cites this paper